HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,470 | -50.8% | 60,650 | -44.5% | 0.00% | – |
| Q2 2023 | $126,868 | +93.3% | 109,369 | +151.7% | 0.00% | – |
| Q1 2023 | $65,617 | +13.6% | 43,455 | +88.1% | 0.00% | – |
| Q4 2022 | $57,742 | -100.0% | 23,097 | -90.1% | 0.00% | -100.0% |
| Q3 2022 | $985,539,000 | +920.4% | 233,540 | +574.7% | 0.00% | – |
| Q2 2022 | $96,579,000 | -93.4% | 34,616 | -86.6% | 0.00% | -100.0% |
| Q1 2022 | $1,473,386,000 | +5.5% | 257,585 | +68.4% | 0.00% | 0.0% |
| Q4 2021 | $1,396,717,000 | +678.5% | 152,981 | +811.5% | 0.00% | – |
| Q3 2021 | $179,421,000 | +235.6% | 16,784 | +387.2% | 0.00% | – |
| Q2 2021 | $53,466,000 | -71.2% | 3,445 | -69.9% | 0.00% | – |
| Q1 2021 | $185,637,000 | -23.2% | 11,452 | +0.3% | 0.00% | – |
| Q4 2020 | $241,662,000 | -21.0% | 11,418 | -44.7% | 0.00% | – |
| Q3 2020 | $305,870,000 | +96.5% | 20,639 | +95.0% | 0.00% | – |
| Q2 2020 | $155,676,000 | -87.3% | 10,583 | -89.9% | 0.00% | -100.0% |
| Q1 2020 | $1,227,969,000 | +340.8% | 104,597 | +782.5% | 0.00% | +200.0% |
| Q4 2019 | $278,546,000 | +16.2% | 11,853 | -8.5% | 0.00% | – |
| Q3 2019 | $239,742,000 | +36.2% | 12,959 | +36.9% | 0.00% | – |
| Q2 2019 | $176,029,000 | -53.9% | 9,469 | -39.4% | 0.00% | -100.0% |
| Q1 2019 | $381,948,000 | +1029.2% | 15,628 | +1098.5% | 0.00% | – |
| Q4 2018 | $33,826,000 | -68.8% | 1,304 | -62.0% | 0.00% | – |
| Q3 2018 | $108,560,000 | -16.4% | 3,430 | +2.6% | 0.00% | – |
| Q2 2018 | $129,914,000 | -58.1% | 3,344 | -70.2% | 0.00% | -100.0% |
| Q1 2018 | $309,920,000 | +80.8% | 11,229 | +18.6% | 0.00% | – |
| Q4 2017 | $171,371,000 | +130.8% | 9,468 | +106.0% | 0.00% | – |
| Q3 2017 | $74,242,000 | +9.3% | 4,597 | -6.3% | 0.00% | – |
| Q2 2017 | $67,920,000 | +904.0% | 4,904 | +987.4% | 0.00% | – |
| Q1 2017 | $6,765,000 | -6.8% | 451 | -18.6% | 0.00% | – |
| Q4 2016 | $7,257,000 | -80.5% | 554 | -74.4% | 0.00% | – |
| Q3 2016 | $37,268,000 | +67.2% | 2,163 | +75.1% | 0.00% | – |
| Q2 2016 | $22,292,000 | -88.2% | 1,235 | -82.5% | 0.00% | – |
| Q4 2015 | $188,930,000 | +26.7% | 7,076 | +15.8% | 0.00% | – |
| Q3 2015 | $149,157,000 | +133.4% | 6,113 | +198.0% | 0.00% | – |
| Q2 2015 | $63,909,000 | +704.5% | 2,051 | +275.6% | 0.00% | – |
| Q1 2015 | $7,944,000 | -41.3% | 546 | -66.4% | 0.00% | – |
| Q3 2014 | $13,528,000 | – | 1,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |